Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.
Chang
Tzu-Hua
TH
Graduate Institute of Medical Sciences, National Defense Medical Center, #161 Sec. 6 Minquan E. Rd., Neihu Dist., Taipei City, Taiwan.
Tsai
Meng-Feng
MF
Su
Kang-Yi
KY
Wu
Shang-Gin
SG
Huang
Cheng-Po
CP
Yu
Sung-Liang
SL
Yu
Yung-Luen
YL
Lan
Chou-Chin
CC
Yang
Chih-Hsin
CH
Lin
Shwu-Bin
SB
Wu
Chin-Pyng
CP
Shih
Jin-Yuan
JY
Yang
Pan-Chyr
PC
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D015153:Blotting, Western; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000077156:Gefitinib; D055786:Gene Knockout Techniques; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011799:Quinazolines / Q000627:therapeutic use; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors / Q000235:genetics / Q000502:physiology*
D000970:Antineoplastic Agents; D011799:Quinazolines; C000604407:SNAI1 protein, human; C000604449:Snai2 protein, mouse; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors; D066246:ErbB Receptors; D000077156:Gefitinib